Long-term central venous catheters (CVCs) have considerably improved the management of
cancer patients because they facilitate chemotherapy, transfusions, parenteral nutrition, and …

Background Over the last decades, many changes have occurred in oncology with new
chemotherapy combinations and more complex application schemes becoming available …

Objective: The prevalence of asymptomatic catheter-related thrombosis of the upper venous
system in children with cancer has not been determined. We evaluated patients with cancer …

Materials and methods This study included 472 patients from our database who were
treated between January 2001 and November 2005. In total, 476 venous ports were placed …

PURPOSE: Although home parenteral antimicrobial therapy has become common, few
studies have carefully examined its adverse effects. SUBJECTS AND METHODS: We …

Background: Chronic indwelling central venous access devices (CICVAD) generally are
placed by the percutaneous subclavian vein approach. The cephalic vein cutdown approach …

Morbidity and mortality after a totally implantable venous access port (TIVAP)-related
infection in oncology patients have rarely been studied. We conducted this study to assess …

Objectives: This study was conducted to evaluate the infectious morbidity associated with 2
common types of implantable port systems used in a cancer center in Taiwan. Methods: This …

Can long-term subcutaneous venous (Mediport) catheters be safely inserted without routine
chest X-ray (CXR) verification? An estimated 500,000 Mediport catheters are inserted yearly …

Central venous catheters are essential to the modern-day management of many illnesses
especially cancer and hematologic disorders. Catheter malfunction due to catheter tip …